112 related articles for article (PubMed ID: 12694721)
21. [Determination of pepsin and gastricsin in human gastric juice].
Pokrovskiĭ AA; Bogdanova LM
Vopr Med Khim; 1968; 14(1):102-6. PubMed ID: 4879030
[No Abstract] [Full Text] [Related]
22. Comparative pepstatin inhibition studies on individual human pepsins and pepsinogens 1,3 and 5(gastricsin) and pig pepsin A.
Roberts NB; Taylor WH
J Enzyme Inhib Med Chem; 2003 Jun; 18(3):209-17. PubMed ID: 14506911
[TBL] [Abstract][Full Text] [Related]
23. A new fluorometric assay for neutral endopeptidase (EC 3.4.24.11).
Carvalho KM; Boileau G; França MS; Medeiros MA; Camargo AC; Juliano L
Braz J Med Biol Res; 1995 Oct; 28(10):1055-9. PubMed ID: 8634676
[TBL] [Abstract][Full Text] [Related]
24. Subsite preferences of pepstatin-insensitive carboxyl proteinases from bacteria.
Narutaki S; Dunn BM; Oda K
J Biochem; 1999 Jan; 125(1):75-81. PubMed ID: 9880800
[TBL] [Abstract][Full Text] [Related]
25. Characterization of new fluorogenic substrates for the rapid and sensitive assay of cathepsin E and cathepsin D.
Yasuda Y; Kageyama T; Akamine A; Shibata M; Kominami E; Uchiyama Y; Yamamoto K
J Biochem; 1999 Jun; 125(6):1137-43. PubMed ID: 10348917
[TBL] [Abstract][Full Text] [Related]
26. Selective neurotensin-derived internally quenched fluorogenic substrates for neurolysin (EC 3.4.24.16): comparison with thimet oligopeptidase (EC 3.4.24.15) and neprilysin (EC 3.4.24.11).
Oliveira V; Campos M; Hemerly JP; Ferro ES; Camargo AC; Juliano MA; Juliano L
Anal Biochem; 2001 May; 292(2):257-65. PubMed ID: 11355859
[TBL] [Abstract][Full Text] [Related]
27. Structural and mechanistic insight into the inhibition of aspartic proteases by a slow-tight binding inhibitor from an extremophilic Bacillus sp.: correlation of the kinetic parameters with the inhibitor induced conformational changes.
Dash C; Phadtare S; Deshpande V; Rao M
Biochemistry; 2001 Sep; 40(38):11525-32. PubMed ID: 11560501
[TBL] [Abstract][Full Text] [Related]
28. Purification and characterization of a neutral endopeptidase-like enzyme from human urine.
Di Marco GS; Quinto BM; Juliano M; Carmona AK; Stella RC; Plavnik FL; Casarini DE
J Hypertens; 1998 Dec; 16(12 Pt 2):1971-8. PubMed ID: 9886885
[TBL] [Abstract][Full Text] [Related]
29. Substrate and inhibitor studies with human gastric aspartic proteinases.
Baxter A; Campbell CJ; Grinham CJ; Keane RM; Lawton BC; Pendlebury JE
Biochem J; 1990 May; 267(3):665-9. PubMed ID: 2111133
[TBL] [Abstract][Full Text] [Related]
30. Specificity of human tissue kallikrein towards substrates containing Phe-Phe pair of amino acids.
Pimenta DC; Chao J; Chao L; Juliano MA; Juliano L
Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):473-9. PubMed ID: 10191281
[TBL] [Abstract][Full Text] [Related]
31. Kinetic assay of human pepsin with albumin-bromphenol blue as substrate.
Gray SP; Billings JA
Clin Chem; 1983 Mar; 29(3):447-51. PubMed ID: 6402323
[TBL] [Abstract][Full Text] [Related]
32. Effects of pressure on the activity and spectroscopic properties of carboxyl proteinases. Apparent correlation of pepstatin-insensitivity and pressure response.
Fujiwara S; Kunugi S; Oyama H; Oda K
Eur J Biochem; 2001 Feb; 268(3):645-55. PubMed ID: 11168403
[TBL] [Abstract][Full Text] [Related]
33. A continuous fluorimetric assay for tumor necrosis factor-alpha converting enzyme.
Jin G; Huang X; Black R; Wolfson M; Rauch C; McGregor H; Ellestad G; Cowling R
Anal Biochem; 2002 Mar; 302(2):269-75. PubMed ID: 11878807
[TBL] [Abstract][Full Text] [Related]
34. Subsite specificity (S3, S2, S1', S2' and S3') of oligopeptidase B from Trypanosoma cruzi and Trypanosoma brucei using fluorescent quenched peptides: comparative study and identification of specific carboxypeptidase activity.
Hemerly JP; Oliveira V; Del Nery E; Morty RE; Andrews NW; Juliano MA; Juliano L
Biochem J; 2003 Aug; 373(Pt 3):933-9. PubMed ID: 12737623
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of gastric peptic activity by antacids and pepstatin.
Holm HA; Berstad A
Scand J Gastroenterol Suppl; 1976; 42():119-21. PubMed ID: 13483
[No Abstract] [Full Text] [Related]
36. Five human gastric aspartic proteinases: N-terminal amino acid sequences and amino acid composition.
Roberts NB; Peek K; Keen JN; Taylor WH
Int J Biochem Cell Biol; 1995 Feb; 27(2):133-7. PubMed ID: 7767781
[TBL] [Abstract][Full Text] [Related]
37. Differences in substrate and inhibitor sequence specificity of human, mouse and rat tissue kallikreins.
Fogaça SE; Melo RL; Pimenta DC; Hosoi K; Juliano L; Juliano MA
Biochem J; 2004 Jun; 380(Pt 3):775-81. PubMed ID: 15040788
[TBL] [Abstract][Full Text] [Related]
38. Studies on acid protease fractions and gastric mucosal atrophy. 1. A modified simple method for separate determination of alkali labile pepsin in gastric juice by alkali treatment or by using a synthetic substrate.
Yamamoto S
Gastroenterol Jpn; 1980; 15(5):488-95. PubMed ID: 6777228
[TBL] [Abstract][Full Text] [Related]
39. Substrate specificities of pepstatin-insensitive carboxyl proteinases from gram-negative bacteria.
Ito M; Dunn BM; Oda K
J Biochem; 1996 Oct; 120(4):845-50. PubMed ID: 8947851
[TBL] [Abstract][Full Text] [Related]
40. Human tissue kallikrein S1 subsite recognition of non-natural basic amino acids.
Melo RL; Barbosa Pozzo RC; Pimenta DC; Perissutti E; Caliendo G; Santagada V; Juliano L; Juliano MA
Biochemistry; 2001 May; 40(17):5226-32. PubMed ID: 11318645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
